FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17973311000001109: Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61914401000001118 Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
61914501000001119 Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Is a Glibenclamide 5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has AMP Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has specific active ingredient Glibenclamide true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start